Results 161 to 170 of about 18,546 (173)

Anakinra for the treatment of rheumatoid arthritis: a safety evaluation

Expert Opinion on Drug Safety, 2018
Julio Ramirez, Juan D Canete
exaly  

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis

Expert Opinion on Biological Therapy, 2004
Roy Fleischmann, Imran Iqbal
exaly  

Anakinra

Reactions Weekly, 2003
openaire   +1 more source

Protein HESylation for half-life extension: Synthesis, characterization and pharmacokinetics of HESylated anakinra

European Journal of Pharmaceutics and Biopharmaceutics, 2014
Robert Liebner, Gerhard Winter, Ahmed Besheer   +2 more
exaly  

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study

Clinical Rheumatology, 2008
Marilynn Punaro, Yu-Nien Sun, Punaro Marilynn   +2 more
exaly  

Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature

Clinical Rheumatology, 2018
Hafize Emine Sönmez, Selcan Demir, Yelda Bilginer   +2 more
exaly  

Anakinra

Reactions Weekly, 2020
openaire   +1 more source

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes

Rheumatology, 2016
Raphaela Goldbach-Mansky, Goldbach-Mansky Raphaela   +1 more
exaly  

Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis

Clinical Therapeutics, 2004
Daniel E Fürst
exaly  

Anakinra

Reactions Weekly, 2007
openaire   +1 more source